HCPCS Level II · Drugs administered other than oral method
J8562Fludarabine phosphate, oral, 10 mg
Terminated 12/31/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J8562
J8562 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing fludarabine phosphate, oral, 10 mg.
It was added to HCPCS effective 01/01/2011, and its current record took effect 01/01/2026.
It was terminated on 12/31/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Oral fludarabine phosphate
- Date added
- 01/01/2011
- Action effective
- 01/01/2026
- Termination date
- 12/31/2025
- BETOS
- O1D
Related J85xx codes
- J8501Aprepitant, oral, 5 mg
- J8502Injection, aprepitant (aponvie), 1 mg
- J8510Busulfan; oral, 2 mg
- J8515Cabergoline, oral, 0.25 mg
- J8522Capecitabine, oral, 50 mg
- J8530Cyclophosphamide; oral, 25 mg
- J8540Dexamethasone, oral, 0.25 mg
- J8541Dexamethasone (hemady), oral, 0.25 mg
- J8560Etoposide; oral, 50 mg
- J8565Gefitinib, oral, 250 mg
- J8597Antiemetic drug, oral, not otherwise specified
Common questions about J8562
Is HCPCS J8562 still valid?
- No. J8562 was terminated on 12/31/2025.
Does Medicare cover J8562?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.